Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study (Q37038646)

17 August 2017

Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study (English)

1 reference

17 August 2017

1 reference

Kristjana Einarsdóttir

object named as

Kristjana Einarsdóttir

4

0 references

Paul W Dickman

object named as

Paul W Dickman

3

0 references

Per Hall

7

object named as

Per Hall

1 reference

17 August 2017

2

Fredrik Granath

1 reference

17 August 2017

Lena U Rosenberg

1

1 reference

17 August 2017

Sara Wedrén

5

1 reference

17 August 2017

Ingemar Persson

6

1 reference

17 August 2017

19 September 2008

1 reference

17 August 2017

Breast Cancer Research

1 reference

17 August 2017

10

1 reference

17 August 2017

5

1 reference

17 August 2017

R78

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2145

17 August 2017

0 references

cites work

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

The decrease in breast-cancer incidence in 2003 in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Safety of hormone therapy after breast cancer: a qualitative systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Histopathologic indicators of breast cancer biology: insights from population mammographic screening

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Molecular evolution of breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Breast cancer with different prognostic characteristics developing in Danish women using hormone replacement therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Breast cancer and hormone-replacement therapy in the Million Women Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Effect of hormone replacement therapy on the pathological stage of breast cancer: population based, cross sectional study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Does a better grade of tumour occurring in women under hormone replacement therapy compensate for their lower probability of detection by screening mammography

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Breast tumours following combined hormone replacement therapy express favourable prognostic factors.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Duration of hormone replacement therapy, breast tumour size and grade in a screening programme

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Breast cancer and hormone-replacement therapy: the Million Women Study

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR2145

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Prognostic characteristics in breast cancers after hormone replacement therapy

20 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614511

Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis

20 October 2018

1 reference

12 December 2020

Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation

1 reference

12 December 2020

Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users

1 reference

12 December 2020

The relationship between breast cancer survival and prior postmenopausal estrogen use

1 reference

12 December 2020

Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee

1 reference

12 December 2020

Low biologic aggressiveness in breast cancer in women using hormone replacement therapy

1 reference

12 December 2020

Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR2145

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

1 reference